Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daughton

Showing results (191-200 of 216) with videos related to

Pageof 22
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2020
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse modelsDeli Huang, Robert K Abbott, Colin Havenar-Daughton, et al.
Journal of Virology|December 9, 2016
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive MacaquesSudhir Pai Kasturi, Pamela A Kozlowski, Helder I Nakaya, et al.
Science Immunology|June 21, 2020
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primatesSudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, et al.
Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.
Cell Reports|November 24, 2016
Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env TrimerColin Havenar-Daughton, Diane G Carnathan, Alba Torrents de la Peña, et al.
Immunity|December 16, 2018
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody TitersMatthias G Pauthner, Joseph P Nkolola, Colin Havenar-Daughton, et al.
Journal of Hepatology|August 29, 2025
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cellsLucia Vincenzetti, Rachel Wong, Roberta Marzi, et al.
Iscience|December 12, 2022
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escapeRoberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2022
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escapeRoberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
Nature Immunology|February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Pageof 22

Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2020
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse modelsDeli Huang, Robert K Abbott, Colin Havenar-Daughton, et al.
Journal of Virology|December 9, 2016
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive MacaquesSudhir Pai Kasturi, Pamela A Kozlowski, Helder I Nakaya, et al.
Science Immunology|June 21, 2020
3M-052, a synthetic TLR-7/8 agonist, induces durable HIV-1 envelope-specific plasma cells and humoral immunity in nonhuman primatesSudhir Pai Kasturi, Mohammed Ata Ur Rasheed, Colin Havenar-Daughton, et al.
Science (New York, N.Y.)|November 2, 2019
A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responsesJon M Steichen, Ying-Cing Lin, Colin Havenar-Daughton, et al.
Cell Reports|November 24, 2016
Direct Probing of Germinal Center Responses Reveals Immunological Features and Bottlenecks for Neutralizing Antibody Responses to HIV Env TrimerColin Havenar-Daughton, Diane G Carnathan, Alba Torrents de la Peña, et al.
Immunity|December 16, 2018
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody TitersMatthias G Pauthner, Joseph P Nkolola, Colin Havenar-Daughton, et al.
Journal of Hepatology|August 29, 2025
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cellsLucia Vincenzetti, Rachel Wong, Roberta Marzi, et al.
Iscience|December 12, 2022
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escapeRoberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
Biorxiv : the Preprint Server for Biology|October 7, 2022
Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escapeRoberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, et al.
Nature Immunology|February 3, 2026
Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332<sub>gp120</sub> glycan-independent epitopeLutz Gieselmann, Andrew T DeLaitsch, Malena Rohde, et al.
Pageof 22